Cellyan Biotechnology reported asset growth of 36.39% for the quarter ended Mar 2026. These growth metrics cover 3 quarters of results from Mar 2025 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Mar2025 | Sep2025 | Mar2026 |
|---|---|---|---|
| Growth Ratios | |||
| Assets Growth (1y) | 8.65% | -5.20% | 36.39% |
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | 19.36% | -69.56% | -70.37% |
| Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) | -20.26% | -39.47% | -25.99% |
| Total Debt Growth (1y) | 4.23% | 37.28% | -0.77% |
Pull Cellyan Biotechnology's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=HKPD&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "HKPD", "statement": "Growth", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=HKPD&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();